On January 15, 2026, ATLMed.org hosted an exceptional session on prostate cancer biomarkers led by Dr. Bamidele A. Adesunloye, MD, MSc, FACP, Chief of Medical Oncology at City of Hope. His expert talk, “Prostate Cancer Biomarkers: From PSA to Precision Medicine,” provided invaluable insights into the progression of prostate cancer diagnostics, shifting from traditional PSA […]
Category Archives: Healthcare Challenges
Smokeless tobacco (ST) use is a leading, yet preventable, cause of oral cancer and related mortality worldwide. Although the health risks of ST are well established, its use continues to rise in many regions, particularly in low- and middle-income countries (LMICs). Addressing this growing public health challenge requires not only effective policy but also strong […]
For much of the past decade, telehealth advocates have focused on payment parity—the principle that virtual visits should be reimbursed at the same rate as in-person care. During the COVID-19 public health emergency, payment parity played a critical role in rapidly expanding access to care, stabilizing physician practices, and normalizing virtual medicine. But as telehealth […]
On November 6, 2025, the Trump administration announced new pricing and coverage agreements with Eli Lilly and Novo Nordisk for widely used glucagon-like peptide-1 (GLP-1) receptor agonists, including tirzepatide (Mounjaro®, Zepbound®) and semaglutide (Ozempic®, Wegovy®). These agreements aim to lower out-of-pocket costs for some patients and expand access under federal health programs beginning in 2026. […]
Rural communities across the United States continue to face deep, long-standing healthcare challenges: long travel distances to clinics, shortages of specialists, hospital closures, and limited access to timely, high-quality care. These barriers contribute to higher rates of chronic disease, later diagnoses, and poorer health outcomes for millions of rural residents. A recent perspective in the […]





